Xenetic Biosciences, Inc. Quarterly Operating Margin in % from Q4 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Xenetic Biosciences, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2019 to Q3 2024.
  • Xenetic Biosciences, Inc. Operating Margin for the quarter ending September 30, 2024 was -173 %, a 15.6% increase year-over-year.
  • Xenetic Biosciences, Inc. annual Operating Margin for 2023 was -178 %, a 54.8% increase from 2022.
  • Xenetic Biosciences, Inc. annual Operating Margin for 2022 was -394 %, a 20.5% increase from 2021.
  • Xenetic Biosciences, Inc. annual Operating Margin for 2021 was -495 %, a 84.5% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -173 +32 +15.6% Jul 1, 2024 Sep 30, 2024
Q2 2024 -199 +11 +5.22% Apr 1, 2024 Jun 30, 2024
Q1 2024 -199 +113 +36.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -178 +216 +54.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -205 +248 +54.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -210 +298 +58.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -313 +129 +29.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -394 +102 +20.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -453 +67.3 +12.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -508 +1.4K +73.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -441 +2.02K +82.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -495 +2.69K +84.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -520 +4.09K +88.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -1.91K +4.73K +71.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 -2.46K +14.9K +85.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 -3.19K +72.3K +95.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -4.61K Jul 1, 2020 Sep 30, 2020
Q2 2020 -6.64K Apr 1, 2020 Jun 30, 2020
Q1 2020 -17.3K Jan 1, 2020 Mar 31, 2020
Q4 2019 -75.5K Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.